Thoracic Outlet Syndrome (TOC) Treatment Market

Global Thoracic Outlet Syndrome (TOC) Treatment Market: Introduction

Thoracic outlet syndrome (TOC) is a group of disorders that cause pain in the neck, shoulder, and arms, and numbness and tingling of the fingers. The thoracic outlet syndrome is caused by the compression of blood vessels and nerves in the space between the collarbone and the first rib known as thoracic outlet. The common causes of thoracic outlet syndrome include damage to the shoulder or neck, injuries caused because of sports-related activities, anatomical defects, tumors in chest, and obesity. The three types of thoracic outlet syndromes are neurogenic, vascular, and non-specific. Treatment of thoracic outlet syndrome includes therapeutic drugs such as anti-inflammatory drugs, anti-coagulation drugs, and muscle relaxants. When medicinal therapy does not improve the symptoms of thoracic outlet syndrome, surgical treatments are performed to relive them.

Key Drivers of Global Thoracic Outlet Syndrome (TOC) Treatment Market

Rise in prevalence of Lung Injuries, Lung Tumors, Congestive Heart Failure, and Lymph or Blood Vessels Blockages

According to the Journal of Aerosol Medicine and Pulmonary Drug Delivery, incidence of acute lung injuries is considerably high (200,000 per year in the U.S.), and overall mortality is also high. According to the World Health Organization, lungs are highly vulnerable to infection and injury from the external environment because of constant exposure to particles, chemicals, and infectious organisms in the ambient air. Globally, at least 2 billion people are exposed to toxic smoke of biomass fuel, typically burned inefficiently in poorly ventilated indoor stoves or fireplaces. Lung cancer is the most common lethal neoplasm in the world, which accounts for 1.6 million deaths each year, and the number is increasing. According to the World Heart Federation, the prevalence of heart failure is rising globally to an estimated number of 26 million, with additional millions of undiagnosed cases.

Rise in Prevalence of Pleural Effusion

According to the Journal of the Nigeria Medical Association, the incidence of pleural effusion in the U.S. is estimated at 1.5 million cases annually. Dyspnea is the most common symptom of pleural effusion. According to Stat Pearls Publishing LLC, pleural effusion is a highly common disease among all pleural diseases and affects 1.5 million people in the U.S. each year.

North America to Account for Major Share of Global Thoracic Outlet Syndrome (TOC) Treatment Market

North America is projected to account for significant share of the global market owing to easy availability of NSAID drugs, rapidly increasing geriatric population, and well-established health care facilities. Europe is anticipated to constitute major share of the global thoracic outlet syndrome treatment market by 2031. The market in Asia Pacific is expected to expand at a high CAGR during the forecast period owing to increase in number of patients with thoracic outlet syndrome in China, India, and Japan, changing health care infrastructure in the region, and easy availability of therapeutic drugs.

Key Players Operating in Global Thoracic Outlet Syndrome (TOC) Treatment Market

The global thoracic outlet syndrome (TOC) treatment market is highly consolidated owing to the presence of small number of key players. Leading players operating in the global thoracic outlet syndrome (TOC) treatment market are:

• Pfizer, Inc.
• Mylan N.V.
• F. Hoffmann-La Roche AG
• Novartis AG
• Allergan plc
• Piramal Critical Care, Inc.
• Apotex, Inc.
• Shire plc
• Validus Pharmaceuticals LLC

Global Thoracic Outlet Syndrome (TOC) Treatment Market: Research Scope

Global Thoracic Outlet Syndrome (TOC) Treatment Market, by Type

• Neurogenic
• Vascular
• Non-specific

Global Thoracic Outlet Syndrome (TOC) Treatment Market, by Drug Class

• Non-steroidal Anti-Inflammatory Drugs (NSAID)
• Skeletal Muscle Relaxants
• Anticoagulants
• Botulinum Toxin Therapeutics

Global Thoracic Outlet Syndrome (TOC) Treatment Market, by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Thoracic Outlet Syndrome (TOC) Treatment Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa